The membrane glycoprotein encoded by the env gene of either the polycythemi
a- or anemia-inducing spleen focus-forming virus (SFFVp or SFFVa, respectiv
ely) is responsible for the induction of erythroleukemia in mice. It has be
en shown that the SFFVp glycoprotein, gp55, interacts with the erythropoiet
in receptor (EPO-R) and promotes EPO-independent proliferation of an EPO-R-
expressing hematopoietic cell line, Ba/F3 (Li et al., Nature 343:762, 1990)
. We show here that when residues within the transmembrane (TM) sequence of
an SFFVp gp55 are altered based on the sequences of the anemia-inducing gp
55s by a methionine-to-isoleucine (M-I) substitution, a di-leucine deletion
(dLL), or both, the resulting mutants display an attenuated phenotype that
resembles an SFFVa: they induce milder erythroproliferative disease withou
t polycythemia in vivo and are unable to promote EPO-independent cell proli
feration in vitro. The dLL mutation directly interferes with EPO-R binding
by decreasing the affinity of gp55 for the receptor. On the other hand, the
M-l mutation hampers the full mitogenic activation of EPO-R while having n
o effect on receptor binding and asserts a dominant negative effect over th
e wild-type SFFVp gp55. Two other sequence changes within the TM sequence d
id not affect the biological activities of the SFFVp gp55. These results in
dicate that the TM sequence of the SFFV env glycoprotein plays a prominent
role in SFFV-induced erythroleukemogenesis through its influence on the mit
ogenic activation of EPO-R. (C) 1998 Academic Press.